PFBT
OCUL icon

Parkside Financial Bank & Trust’s Ocular Therapeutix OCUL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Sell
127
-2
-2% -$18 ﹤0.01% 2339
2026
Q1 		$1.09K Hold
129
– – ﹤0.01% 2329
2025
Q4 		$1.57K Hold
129
– – ﹤0.01% 2187
2025
Q3 		$1.51K Hold
129
– – ﹤0.01% 2122
2025
Q2 		$1.2K Buy
+129
New +$1.01K ﹤0.01% 2193

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parkside Financial Bank & Trust's OCUL Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Ocular Therapeutix (OCUL) stake by 1.6% in Q2 2026, selling an estimated $18 and leaving 127 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

Parkside Financial Bank & Trust first reported a position in OCUL in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.57K in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Parkside Financial Bank & Trust held 127 shares of Ocular Therapeutix worth $1.25K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 2 Ocular Therapeutix shares in Q2 2026, an estimated $18.
  • Ocular Therapeutix made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2339 holding.
  • Parkside Financial Bank & Trust first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Ocular Therapeutix position peaked at $1.57K in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.